Correction: YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma

Le résumé fourni par la source

Following the publication of the original article [1], the authors noticed that in Figure 2D the image of caspase 9 for BEL-7402 cells was inadvertently duplicated from the adjacent HepG2 caspase 9 panel, and the image of Actin for BEL-7402 was misused.They wish to formally request an erratum to rectify this issue.In the correct Figure 2, provided below, they have updated the correct Figure 2D.They are confident that the inadvertent panel duplication did not have any effect on their analyses or on any conclusions drawn from the paper, and they apologize for the error. Molecular CancerThe original article can be found online at h t t p s : / / d o i . o r g / 1 0 . 1 1 8 6 / 1 4 7 6 -4 5 9 8 -1 3 -7.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.